[1]The Global Burden of Disease.A comprehensive assessment of the mortality and disability from diseases,injuries and frisk factors in 1990 and projected to 2020[M].Boston:Harvard School of Public Health on behalf of the World Health Organization and the the World Bank,1996:21.
[2]GBD 2016 Disease and Injury Incidence and Prevalence Collaborators.Global,regional,and national incidence,prevalence,and years lived with disability for 328 diseases and injuries for 195 countries,1990-2016:A systematic analysis for the global burden of disease study 2016[J].Lancet,2017,390(10100):1211-1259.
[3]Vos T,Flaxman AD,Naghavi M,et al.Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990—2010:A systematic analysis for the global burden of disease study 2010[J].Lancet,2012,380(9859):2163-2196.
[4]Hootman JM,Helmick CG,Barbour KE,et al.Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults,2015—2040[J].Arthritis Rheumatol,2016,68(7):1582-1587.
[5]Dougados M,Hochberg MC.Management of osteoarthritis.In:Hochberg MC,Silman AJ,Smolen JS,et al,editors.Rheumatology[M]//5th ed.Philadelphia:Mosby/Elsevier,2011:1793-1799.
[6]裴福兴.中国髋、膝关节置换的现状及展望[J].中国骨与关节杂志,2012,1(1):4-8.
[7]Lee S,Kim SJ.Prevalence of knee osteoarthritis,risk factors,and quality of life:The fifth korean national health and hutrition examination survey[J].Int J Rheum Dis,2017,20(7):809-817.
[8]Zhang W,Nuki G,Moskowitz RW,et al.OARSI recommendations for the management of hip and knee osteoarthritis:partⅢ:Changes in evidence following systematic cumulative update of research published through January 2009[J].Osteoarthritis Cartilage,2010,18(4):476-499.
[9]Hochberg MC,Altman RD,April KT,et al.American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand,hip,and knee[J].Arthritis Care Res (Hoboken),2012,64(4):465-474.
[10]GlynJones S,Palmer AJ,Agricola R,et al.Osteoarthritis[J].Lancet,2015,386(9991):376-387.
[11]Wright EA,Katz JN,Abrams S,et al.Trends in prescription of opioids from 2003-2009 in persons with knee osteoarthritis[J].Arthritis Care Res (Hoboken),2014,66(10):1489-1495.
[12]Power JD,Perruccio AV,Gandhi R,et al.Factors associated with opioid use in pre-surgical knee,hip and spine osteoarthritis patients[J].Arthritis Care Res (Hoboken),2019,71(9):1178-1185.
[13]田 野,徐子悦,管晓东,等.我国2014-2016年阿片类药物使用情况分析[J].中国药房,2019,30(9):1153-1157.
[14]Campbell CI,Weisner C,LeResche L,et al.Age and gender trends in long-term opioid analgesic use for noncancer pain[J].Am J Public Health,2010,100(12):2541-2547.
[15]Fisher JE,Ballantyne PJ,Hawker GA.Older adults living with osteoarthritis:examining the relationship of age and gender to medicine use[J].Can J Aging,2012,31(3):323-333.
[16]Devin CJ,Lee DS,Armaghani SJ,et al.Approach to pain management in chronic opioid users undergoing orthopaedic surgery[J].J Am Acad Orthop Surg,2014,22(10):614-622.
[17]Bijlsma JW,Berenbaum F,Lafeber FP.Osteoarthritis:An update with relevance for clinical practice[J].Lancet,2011,377(9783):2115-2126.
[18]Shiri R,Falah-Hassani K,Helivaara M,et al.Risk factors for low back pain:A populationbased longitudinal study[J].Arthritis Care Res (Hoboken),2018,71(2):290-299.
[19]Stefanik JJ,Felson DT,Apovian CM,et al.Changes in pain sensitization after bariatric surgery[J].Arthritis Care Res (Hoboken),2018,70(10):1525-1528.
[20]Stokes A,Berry KM,Collins JM,et al.The contribution of obesity to prescription opioid use in the United States[J].Pain,2019,160(10):2255-2262.
[21]Christensen R,Astrup A,Bliddal H.Weight loss:the treatment of choice for knee osteoarthritis?A randomized trial[J].Osteoarthr Cartil,2005,13(1):20-27.
[22]Plesner K,Jensen HI,Hjsted J.Smoking history,nicotine dependence and opioid use in patients with chronic nonmalignant pain[J].Acta Anaesthesiol Scand,2016,60(7):988-994.
[23]Parker MA,Streck JM,Sigmon SC.Associations between opioid and nicotine dependence in nationally representative samples of United States adult daily smokers[J].Drug Alcohol Depend,2018(186):167-170.
[24]John WS,Zhu H,Mannelli P,et al.Prevalence and patterns of opioid misuse and opioid use disorder among primary care patients who use tobacco[J].Drug Alcohol Depend,2019(194):468-475.
[25]Hina N,Fletcher D,Poindessous-Jazat F,et al.Hyperalgesia induced by low-dose opioid treatment before orthopaedic surgery:An observational case-control study[J].Eur J Anaesthesiol,2015,32(4):255-261.
[26]Weick J,Bawa H,Dirschl DR,et al.Preoperative opioid use is associated with higher readmission and revision rates in total knee and total hip arthroplasty[J].J Bone Joint Surg Am,2018,100(14):1171-1176.
[27]Driesman A,Kaplan D,Feng JE,et al.Tramadol in knee osteoarthritis:Does preoperative use affect patient-reported outcomes after total knee arthroplasty?[J].J Arthroplasty,2019,34(8):1662-1666.
[28]Bedard NA,Pugely AJ,Westermann RW,et al.Opioid use after total knee arthroplasty:trends and risk factors for prolonged use[J].J Arthroplasty,2017,32(8):2390-2394.